Ocumension Therapeutics
歐康維視生物

10 JUL 2020

Ocumension Therapeutics is a China-based ophthalmic pharmaceutical platform company dedicated to identifying, developing and commercializing first- or best-in-class ophthalmic therapies. The company vision is to provide a world-class pharmaceutical total solution to address significant unmet ophthalmic medical needs in China. Since the inception, Ocumension Therapeutics has focused on building a platform integrating specialized capabilities in each major functionality involved in an ophthalmic drug’s development cycle, from research and development, manufacturing to commercialization. Ocumension Therapeutics believes its platform positions it well to achieve leadership in China ophthalmology, with a first-mover advantage over future competitors.

歐康維視是一家中國眼科醫藥平台公司，致力於識別、開發和商業化同類首創或同類最佳的眼科療法。公司的願景是提供世界一流的藥物整體解決方案，以滿足中國眼科醫療的巨大需求缺口。自成立以來，歐康維視一直專注於構建整合從研發、製造到商業化的眼科藥物開發全週期專業能力於一體的眼科醫藥平台。歐康維視相信，公司的平台令其成為中國眼科業界領導者的道路上處於有利地位，相對未來的競爭對手具備先發優勢。